Literature DB >> 15599525

Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.

Maren Bienert1, Barry McCook, Brian I Carr, David A Geller, Mike Sheetz, Nikhil Amesur, Norbert Avril.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15599525     DOI： 10.1007/s00259-004-1710-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate.

Authors:  B N Gray; M A Burton; D K Kelleher; J Anderson; P Klemp
Journal:  J Surg Oncol       Date:  1989-11       Impact factor: 3.454

2.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.

Authors:  B Gray; G Van Hazel; M Hope; M Burton; P Moroz; J Anderson; V Gebski
Journal:  Ann Oncol       Date:  2001-12       Impact factor: 32.976

3.  Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.

Authors:  R S Stubbs; R J Cannan; A W Mitchell
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

4.  Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.

Authors:  Ching-yee Oliver Wong; Riad Salem; Subha Raman; Vanessa L Gates; Howard J Dworkin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-29       Impact factor: 9.236
  4 in total
  1 in total

1.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.